How are Life Sciences M&A deals faring in a volatile macroeconomic climate?

The team at SRS Acquiom recently interviewed industry experts to learn more about the current state of Life Sciences M&A. In this article, we cover experts’ views on the pace of deals, regulatory impacts, and thoughts on what’s next for Life Sciences M&A. Inform your next negotiation with new perspectives:

  • What’s weighing on Life Sciences M&A
  • Who the buyers are
  • Issues that matter when structuring deals and earnouts
  • Information rights
  • Impact of RWI
  • And more

Gain fresh insights on life sciences M&A deals and put them to use on your next transaction.

Download the article below.

Related Insights